Ionis Pharmaceuticals | IONS - Sales Revenues

Stock Price
83.15
Daily Change
0.01 0.01%
Monthly
4.67%
Yearly
157.27%
Q1 Forecast
80.57

Ionis Pharmaceuticals reported $157M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Agios Pharmaceuticals USD 19.97M 7.07M Dec/2025
Alnylam Pharmaceuticals USD 1.1B 150M Dec/2025
Arrowhead Research USD 264.03M 7.56M Dec/2025
Astellas Pharma JPY 571.21B 46.89B Dec/2025
BioCryst Pharmaceuticals USD -86.95M 204.03M Dec/2024
BioMarin Pharmaceutical USD 776M 49M Sep/2025
Celltrion KRW 1.33T 300B Mar/2026
Cspc Pharmaceutical CNY 6.62B 358.95M Sep/2025
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Divis Laboratories Ltd INR 26.04B 1.11B Dec/2025
Esperion Therapeutics USD 51.63M 22.2M Sep/2024
Exelixis USD 598.66M 860K Dec/2025
Halozyme Therapeutics USD 451.76M 97.76M Dec/2025
Ionis Pharmaceuticals USD 157M 295M Sep/2025
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Knight Therapeutics CAD 92.26M 3.31M Sep/2024
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Medical Developments International AUD 9.53M 1.99M Jun/2025
Moderna USD 678M 342M Dec/2025
Nektar Therapeutics USD 24.12M 635K Sep/2024
Neuren Pharmaceuticals AUD 14.14M 179.96M Jun/2025
Neurocrine Biosciences USD 805.5M 10.6M Dec/2025
Novartis USD 13.91B 144M Sep/2025
OPKO Health USD 151.67M 5.14M Sep/2025
Organigram Holdings CAD 80.06M 9.27M Sep/2025
Pfizer USD 17.58B 880M Dec/2025
Pharma Mar EUR 35.7M 20.69M Sep/2025
PTC Therapeutics USD 164.7M 46.3M Dec/2025
Qiagen NV USD 457.38M 6.06M Dec/2025
Regeneron Pharmaceuticals USD 3.88B 130M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sarepta Therapeutics USD 399.4M 211.69M Sep/2025
Sartorius EUR 927.6M 84.4M Dec/2025
Sino Biopharmaceutical CNY 17.57B 4.58B Jun/2025
Tilray USD 217.51M 74.75M Dec/2025
Ultragenyx Pharmaceutical USD 207M 47M Dec/2025
Vertex Pharmaceuticals USD 3.19B 110M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M Sep/2025